This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

February 2022

Andreas Kuhn, PhD
Vice President, RNA Biochemistry & Manufacturing at BioNTech RNA Pharmaceuticals GmbH

Agenda Sessions

  • KEYNOTE: Usage of an mRNA Platform Technology for “Light Speed” Development of a Vaccine against SARS-CoV-2”